Endovia Health Sciences, Inc. (EDVA) stock
EDVANYSEBeveragesFiscal year ends December 31
$0.18+0.02 (+13.45%)
Close on Nov 13, 2026Market cap $137.15KP/E –Yield –
Endovia Health Sciences total assets
Total assets on the balance sheet at the end of each period.
Endovia Health Sciences's total assets was $1.08M at Jun 30, 2026. For fiscal 2025 it was $965.69K, down 65.0% from the year before. Over ten years it grew 14.9% a year on average. The highest annual figure on record is $17.30M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $965.69K | -65.0% |
| FY2024 | Dec 31, 2024 | $2.76M | -72.1% |
| FY2023 | Dec 31, 2023 | $9.90M | -42.8% |
| FY2022 | Dec 31, 2022 | $17.30M | +5.6% |
| FY2021 | Dec 31, 2021 | $16.39M | +77.6% |
| FY2020 | Dec 31, 2020 | $9.23M | +1424.1% |
| FY2019 | Dec 31, 2019 | $605.31K | +48.3% |
| FY2018 | Dec 31, 2018 | $408.30K | +69.4% |
| FY2017 | Dec 31, 2017 | $241.03K | -32.2% |
| FY2016 | Dec 31, 2016 | $355.33K | +48.2% |
| FY2015 | Dec 31, 2015 | $239.75K | +43.8% |
| FY2014 | Dec 31, 2014 | $166.71K | +74.2% |
| FY2013 | Dec 31, 2013 | $95.72K | +338.8% |
| FY2012 | Dec 31, 2012 | $21.81K | -5.6% |
| FY2011 | Dec 31, 2011 | $23.12K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.08M | -95.2% |
| Q1 FY2026 | Mar 31, 2026 | $769.95K | -69.3% |
| Q4 FY2025 | Dec 31, 2025 | $965.69K | -65.0% |
| Q3 FY2025 | Sep 30, 2025 | $22.49M | +168.9% |
| Q2 FY2025 | Jun 30, 2025 | $22.24M | +176.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.51M | -70.7% |
| Q4 FY2024 | Dec 31, 2024 | $2.76M | -72.1% |
| Q3 FY2024 | Sep 30, 2024 | $8.36M | -25.6% |
| Q2 FY2024 | Jun 30, 2024 | $8.06M | -38.6% |
| Q1 FY2024 | Mar 31, 2024 | $8.56M | -50.5% |
| Q4 FY2023 | Dec 31, 2023 | $9.90M | -38.0% |
| Q3 FY2023 | Sep 30, 2023 | $11.24M | -33.3% |
| Q2 FY2023 | Jun 30, 2023 | $13.13M | -36.3% |
| Q4 FY2022 | Dec 31, 2022 | $17.30M | +5.6% |
| Q3 FY2022 | Sep 30, 2022 | $15.96M | -18.0% |
| Q2 FY2022 | Jun 30, 2022 | $16.87M | -26.1% |
| Q1 FY2022 | Mar 31, 2022 | $20.61M | +76.0% |
| Q4 FY2021 | Dec 31, 2021 | $16.39M | +77.6% |
| Q3 FY2021 | Sep 30, 2021 | $19.47M | +49.4% |
| Q2 FY2021 | Jun 30, 2021 | $22.84M | +108.9% |
| Q1 FY2021 | Mar 31, 2021 | $11.71M | +2.1% |
| Q4 FY2020 | Dec 31, 2020 | $9.23M | +1424.1% |
| Q3 FY2020 | Sep 30, 2020 | $13.04M | +2503.3% |
| Q2 FY2020 | Jun 30, 2020 | $10.93M | +1877.1% |
| Q1 FY2020 | Mar 31, 2020 | $11.47M | +2619.4% |
| Q4 FY2019 | Dec 31, 2019 | $605.31K | +48.3% |
| Q3 FY2019 | Sep 30, 2019 | $500.79K | +42.8% |
| Q2 FY2019 | Jun 30, 2019 | $553.05K | +65.0% |
| Q1 FY2019 | Mar 31, 2019 | $421.95K | +17.2% |
| Q4 FY2018 | Dec 31, 2018 | $408.30K | +69.4% |
| Q3 FY2018 | Sep 30, 2018 | $350.70K | -0.8% |
| Q2 FY2018 | Jun 30, 2018 | $335.22K | +15.2% |
| Q1 FY2018 | Mar 31, 2018 | $360.05K | +14.0% |
| Q4 FY2017 | Dec 31, 2017 | $241.03K | -32.2% |
| Q3 FY2017 | Sep 30, 2017 | $353.48K | +28.6% |
| Q2 FY2017 | Jun 30, 2017 | $291.01K | +14.5% |
| Q1 FY2017 | Mar 31, 2017 | $315.70K | – |
| Q4 FY2016 | Dec 31, 2016 | $355.33K | – |
| Q3 FY2016 | Sep 30, 2016 | $274.83K | – |
| Q2 FY2016 | Jun 30, 2016 | $254.17K | – |
See a number that looks wrong?